The Venture Codex Logo

The Venture Codex

Juno Pharmaceuticals

15-17 Chapel St, Cremorne, VIC, 3121, Australia

Overview

Pharmaceutical company producing and distributing various medications.

Founded

2012

Deals ยท 12mo

0

Links

WebsiteLinkedIn

Stage focus

Series A

Geographic focus

Canada

Sector focus

Manufacturing
Medical
Medical Device
Pharmaceutical
...

Investment portfolio

1rounds
NAMEDATESIZE
FluidAI Medical
Oct 2023Participated
$15 MSeries A
FluidAI Medical
Oct 2023Participated
$15 MSeries A
1
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Juno Pharmaceuticals: 1 funding rounds are recorded in the selected participation categories.All available history.
Juno Pharmaceuticals: 1 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series A01

Monthly Deal Activity

Juno Pharmaceuticals: 1 deals are recorded across 37 months.All available history.
Juno Pharmaceuticals: 1 deals are recorded across 37 months. All available history
MonthDeals
Oct '231
Nov '230
Dec '230
Jan '240
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Juno Pharmaceuticals: Health & Life Sciences is the largest displayed sector by deal count (1 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Juno Pharmaceuticals: Health & Life Sciences is the largest displayed sector by deal count (1 deals). All available history
SectorDeals
Health & Life Sciences1
AI & Machine Learning1

Deal Size Distribution

Juno Pharmaceuticals: 1 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Juno Pharmaceuticals: 1 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M0
$10M-$25M1
$25M-$50M0
$50M-$100M0
$100M-$250M0
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Juno Pharmaceuticals: Canada has the largest recorded deal count among the displayed regions (1 deals).All available history.

Top 1 of 1 regions; European countries are grouped as Europe.

Juno Pharmaceuticals: Canada has the largest recorded deal count among the displayed regions (1 deals). All available history
RegionDeals
Canada1
Juno Pharmaceuticals: 7 co-investors are shown, with Boutique Venture Partners sharing 1 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Juno Pharmaceuticals: 7 co-investors are shown, with Boutique Venture Partners sharing 1 recorded deals. All available history
Co-investorShared deals
Boutique Venture Partners1
Cur8 Capital1
Graphene Ventures1
Kyto Technology & Life Science1
Leva Capital1
SOSV1
ThresholdImpact1

Investment Strategy

Juno Pharmaceuticals: Led accounts for 0% and participating for 100% of round participation.All available history.
Juno Pharmaceuticals: Led accounts for 0% and participating for 100% of round participation. All available history
CategoryDeals (count)Share (%)
Led00%
Participating1100%
Juno Pharmaceuticals: Single-lead accounts for 0% and co-led for 0% of lead dynamics.All available history.
Juno Pharmaceuticals: Single-lead accounts for 0% and co-led for 0% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead00%
Co-led00%

Lead dynamics requires at least one led deal in this range

Team

Craig Podolsky

Co-Founder & President